Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

BIO, Tocris Bioscience™

Catalog No. 319450
Click to view available options
Quantity:
10 mg
50 mg
This item is not returnable. View return policy
This item is not returnable. View return policy

Potent GSK-3 inhibitor; also inhibits cdks

Potent ATP-competitive glycogen synthase kinase-3 (GSK-3) inhibitor (IC50 = 5 nM). Also inhibits cyclin-dependent kinases (cdks; IC50 values are <100 nM for cdk2 and 5 and sub micromolar for cdk1, cdk4 and cdk9). Maintains self-renewal and pluripotency in embryonic stem cells via activation of the Wnt signaling pathway in vitro; also promotes proliferation and dedifferentiation in cardiomyocytes.

Negative Control also available.

Chemical Identifiers

CAS 667463-62-9
Molecular Formula C16H10BrN3O2
Molecular Weight (g/mol) 356.179
InChI Key WNWSUJQVZJJGLF-UHFFFAOYSA-N
Synonym bio, 6-bromo-3-3-hydroxyamino indol-2-ylidene-1h-indol-2-one, z,3e-6'-bromo-3-hydroxyimino-1h,1'h-2,3'-biindolyliden-2'-one, 2h-indol-2-one, 6-bromo-3-3e-1,3-dihydro-3-hydroxyimino-2h-indol-2-ylidene-1,3-dihydro-, 3z, 6-bromo-3-3-hydroxyamino indol-2-ylidene indolin-2-one, 2z,3e-6'-bromo-3-hydroxyimino-2,3'-biindolinylidene-2'-one, 6-bromo-3-3-hydroxyamino-2h-indol-2-ylidene-1,3-dihydro-2h-indol-2-one
PubChem CID 24906282
IUPAC Name 6-bromo-3-[3-(hydroxyamino)indol-2-ylidene]-1H-indol-2-one
SMILES C1=CC2=C(C(=C3C4=C(C=C(C=C4)Br)NC3=O)N=C2C=C1)NO

Specifications

Quantity 50 mg
Formula Weight 356.17
Percent Purity >98%
Chemical Name or Material BIO
Recommended Storage Store at +4°C
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.